Scientia Press

1. Biophotonic Therapy is the use of light to activate the healing properties of the blood. BT is photomedicine and has a well-characterized clinical profile. A dozen books and some 400 articles in the German, Russian, and English-language medical literature describe Biophotonic Therapy. Other common names for BT are Ultraviolet Blood Irradiation and Photoluminescence Therapy.
2. In BT’s extracorporeal form, ultraviolet and visible light are used to treat a small amount of blood, which is then reinfused.
3. In BT’s intravenous form, a low-intensity laser (generally at 632.8 nm) shines through a waveguide inside a needle into the blood. BT can also be administered sublingually.
   Continue reading 10 Key Points about Biophotonic Therapy

Identifying the best ways to stimulate the immune system to fight infectious diseases and cancer makes eminent sense and could provide highly attractive benefits. But it is not easy to do. Here is a list of category-leading immunostimulants, followed by a discussion of the issues involved.

Cytokines: IL-2 has shown itself to be an effective general immunostimulant in scores of clinical trials against different indications and appears promising against HIV (Cohen and Powderly, 2004). Used in high doses, IL-2 has significant side effects, so it is best used as a low-dose adjuvant. Other cytokines of proven general merit include G-CSF and GM-CSF, both for hematopoiesis. Interferons may work in specific cases, but their side effects make them less suitable as broad-spectrum adjuvants.

Microbial fragments/toxins: Of the large number of candidates, beta-glucans (also found in plants) are the most frequently investigated as an approach to provoking a general immune response (Wagner, 1999).

The treatment of severe depression remains a forbidding scientific frontier (Nemeroff, 2007). No current pharmacological therapy seems more than occasionally effective on those who suffer from it. Of the traditional device-based treatments, only Electro-Convulsive Therapy (ECT) has shown itself effective, and ECT is only effective to some extent and in some cases. ECT also comes with a significant price tag and consistent mid-level side effects. Many patients do not respond to any therapy, while the suicide rate among victims of severe depression remains tragically high.

Treatment-resistant depression, whether moderate or severe, is an unusually expensive disorder because it tends to affect people at relatively young ages, making them less able to perform at work, frequently absent from work, or simply unable to work at all for decades on end (Crown, 2002). Researchers are currently investigating various novel approaches to the treatment of severe depression. But expanding the range of possible approaches to such a refractory syndrome can in the long run lead to a more optimal outcome. Here are three new approaches not currently under consideration.

Amid the fanfare regarding initiatives to treat the devastating HIV/AIDS epidemic, a noteworthy finding has been overlooked. After more than two decades of debate, experimentation by patients, and scattered clinical testing of non-drug therapies of HIV, we now know much better which ones actually work.

It is a little-known fact that one can treat respiratory infections quite effectively without drugs, primarily with the use of physical therapies and correctly applied remedies. Here are three methods:

1. Therapeutic Gargling (TG). Many respiratory viral and bacterial infections commence with a sore throat or a small infection in the inside lining of the mouth–for instance, inside the cheek. In these cases, the invading microbe appears to establish a beachhead in the throat or mouth lining where it can safely multiply before the immune system can develop a response sufficient to wipe it out. Once the numbers of microbes reach a high enough level, they can break out and spread the infection throughout the respiratory tract or even system-wide.

The finding that NSAIDs can cause heart attacks and strokes in certain patients  has disrupted the lives of millions of arthritis patients as well as throwing a scare into the pharmaceutical industry.

But it needs to be put in perspective. There is no better place to start than with the famous dictum of the Swiss Renaissance physician Paracelsus: “All things are poison, and nothing is without poison. It is the dose alone that makes a thing not a poison.” In the case of the painkillers, it is likely that lower doses and limits on the duration of therapy would avoid most problems. Quite possibly, some of the people who suffered heart damage belonged to high risk categories for whom most or all prescription painkillers would be dangerous. In fact, NSAIDs and other pain relief drugs have shown themselves to be very effective and safe for certain groups of patients in modest doses for limited periods of time, so it is unreasonable to withdraw them from the market. Of course, they should compete there on the basis of their merits compared to other drugs.